Literature DB >> 24332654

Synthesis and anticancer evaluation of 3-substituted quinolin-4-ones and 2,3-dihydroquinolin-4-ones.

Santosh Rajput1, Christopher R Gardner1, Timothy W Failes2, Greg M Arndt2, David Stc Black1, Naresh Kumar3.   

Abstract

A series of 3-aryl-5,7-dimethoxyquinolin-4-ones 8 and 3-aryl-5,7-dimethoxy-2,3-dihydroquinolin-4-ones 13 were synthesized in good yields. Demethylation under a range of conditions afforded the corresponding 5-hydroxy and 5,7-dihydroxy derivatives. Biological evaluation against a range of cancer cells lines showed that the quinolin-4-one scaffold was more cytotoxic than the reduced 2,3-dihydroquinolin-4-one scaffold. The most active monohydroxy compound 15f demonstrated 85.9-99% reduction in cell viability against the cell lines tested.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anticancer; Dihydroquinolin-4-one; Quinolin-4-one

Mesh:

Substances:

Year:  2013        PMID: 24332654     DOI: 10.1016/j.bmc.2013.11.047

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Synthesis and Anticancer Properties of New 3-Methylidene-1-sulfonyl-2,3-dihydroquinolin-4(1H)-ones.

Authors:  Agata Jaskulska; Katarzyna Gach-Janczak; Joanna Drogosz-Stachowicz; Tomasz Janecki; Anna Ewa Janecka
Journal:  Molecules       Date:  2022-06-03       Impact factor: 4.927

2.  An isoflavone derivative potently inhibits the angiogenesis and progression of triple-negative breast cancer by targeting the MTA2/SerRS/VEGFA pathway.

Authors:  Xiaotong Zhang; Gengyi Zou; Xiyang Li; Lun Wang; Tianyu Xie; Jin Zhao; Longlong Wang; Shunchang Jiao; Rong Xiang; Haoyu Ye; Yi Shi
Journal:  Cancer Biol Med       Date:  2020-08-15       Impact factor: 4.248

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.